Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Managing Pain and Comorbidities in HS Patients
Description
The presentation focuses on managing pain and comorbidities in patients with Hidradenitis Suppurativa (HS). It highlights the importance of pain management in improving patients' quality of life, discussing various pain types (nociceptive, neuropathic, and nociplastic) and their respective management strategies, from topical treatments like diclofenac gel to systemic options including acetaminophen and opioids like tramadol. Chronic pain management may require medications such as gabapentin, duloxetine, or nortriptyline. The speaker emphasizes the prevalence of mental health issues among HS patients, including high rates of depression and anxiety, and suggests screening tools like the PHQ-2 and GAD-7 to identify at-risk individuals. Co-managing HS with conditions like inflammatory bowel disease (IBD) and polycystic ovary syndrome (PCOS) is addressed, recommending coordination with GI specialists and the use of TNF inhibitors for both conditions. The importance of wound care is also underlined, advising on non-adherent dressings and the challenges of obtaining these supplies through insurance. Finally, the speaker stresses the need for a comprehensive approach to patient care, involving effective management of pain, mood, and comorbidities to enhance overall patient outcomes.
View moreConclusions
- Pain significantly impacts the quality of life in HS patients, necessitating effective management strategies.
- A multimodal approach to pain management, including disease-directed therapies and pain-specific treatments, is essential for HS patients.
- Pain in HS can be classified into nociceptive, neuropathic, and nociplastic types, each requiring different treatment strategies.
- Available treatment options for acute pain include topical treatments, acetaminophen, ibuprofen, and, if necessary, opioids like tramadol or hydrocodone.
- Chronic pain management may involve antidepressants such as SNRIs or TCAs, along with anticonvulsants like gabapentin or pregabalin.
- Patients with HS often have comorbid mental health issues, with significant rates of depression and anxiety, thus necessitating routine screening and referrals to mental health providers.
- For patients with inflammatory bowel disease (IBD) and HS overlap, higher doses of certain biologics may be required, emphasizing collaboration with gastroenterology specialists.
- Polycystic ovarian syndrome (PCOS) is prevalent in HS patients, and effective management may involve hormonal contraceptives, spironolactone, or lifestyle interventions.
- Wound care management for HS patients is critical, focusing on non-adherent dressings and effective communication with patients about their needs.
- Overall, comprehensive care for HS patients should address both physical and psychological aspects of their condition.
- Savage et al, JAAD, 2021
- Oriana M. Damas, Graeme Syme, Gina L. Trakman, Chu Kion Yao, Liam McKeever, and James D. Lewis. Clinical Gastroenterology and Hepatology 2020;18:1381-1392. Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases.